Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Filamon LTD
PMV Pharmaceuticals, Inc
Mayo Clinic
Tomsk National Research Medical Center of the Russian Academy of Sciences
National Institutes of Health Clinical Center (CC)
UMC Utrecht
Thomas Jefferson University
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Eastern Cooperative Oncology Group
ViroMissile, Inc.
University of California, Davis
Replimune Inc.
Hospices Civils de Lyon
National Institutes of Health Clinical Center (CC)
Carevive Systems, Inc.
University of Pennsylvania
Washington University School of Medicine
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
Tianjin Medical University Cancer Institute and Hospital
Ulsan University Hospital
Abramson Cancer Center at Penn Medicine
Baylor College of Medicine
University of Colorado, Denver
Poitiers University Hospital
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Alliance for Clinical Trials in Oncology
Centre Paul Strauss
Case Comprehensive Cancer Center
SystImmune Inc.
Daiichi Sankyo
Institut Curie
University of Nebraska
EXoPERT
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau
HealthPartners Institute
Adela, Inc